Alar Irs

Tartu, Estonia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.

Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.

Journal: BMJ open

Published: May 27, 2026

Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial.

Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial.

Journal: Scientific reports

Published: October 08, 2025

Pharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6.

Pharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6.

Journal: NPJ genomic medicine

Published: July 21, 2025

Clinical practice guideline implementation: challenges and solutions for improved cardiovascular care: A Report from the European Society of Cardiology Cardiovascular RoundTable.

Clinical practice guideline implementation: challenges and solutions for improved cardiovascular care: A Report from the European Society of Cardiology Cardiovascular RoundTable.

Journal: European heart journal. Quality of care & clinical outcomes

Published: July 10, 2025

Cardiovascular Trials in Hemodialysis: Closing the Evidence Gap.

Cardiovascular Trials in Hemodialysis: Closing the Evidence Gap.

Journal: Journal of the American College of Cardiology

Published: March 10, 2025

Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).

Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).

Journal: European heart journal. Quality of care & clinical outcomes

Published: September 23, 2024

Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).

Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).

Journal: European heart journal

Published: May 09, 2024

Cohort profile: the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)-acute coronary syndrome and percutaneous coronary intervention.

Cohort profile: the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)-acute coronary syndrome and percutaneous coronary intervention.

Journal: European heart journal. Quality of care & clinical outcomes

Published: March 19, 2024

The European Innovation Network as a hub for medicines innovation in Europe.

The European Innovation Network as a hub for medicines innovation in Europe.

Journal: Nature reviews. Drug discovery

Published: March 12, 2024

Will the ROB-ME checklist prevent omission bias in meta-analyses?

Will the ROB-ME checklist prevent omission bias in meta-analyses?

Journal: BMJ (Clinical research ed.)

Published: November 20, 2023

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.

Journal: European heart journal

Published: July 24, 2023

Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study.

Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study.

Journal: European heart journal open

Published: September 09, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026